Revolutionizing Orthopedic Surgery: Catalyst OrthoScience Secures $20M in Funding for Innovative Total Shoulder System

Catalyst OrthoScience is thrilled to announce a significant advancement in our mission to revolutionize orthopedic surgery through the successful raising of $20 million in funding. Established by a board-certified orthopedic surgeon, our company combines expertise from a dedicated team of biomedical industry professionals, boasting over a century of collective experience in medical devices. This new influx of capital will be instrumental in enhancing our cutting-edge Catalyst CSR Total Shoulder System, a pioneering solution conceptualized by Dr. Steven Goldberg, a fellowship-trained shoulder specialist. The Catalyst CSR system is designed with several groundbreaking features: it preserves as much of the patient’s bone as possible, mimics the natural elliptical shape of the human shoulder, and vastly enhances the consistency and reproducibility of surgical procedures. The funding will allow Catalyst OrthoScience to accelerate product development, invest in clinical trials, and expand our marketing efforts to bring our innovative solutions to market more swiftly. As we continue our journey toward making orthopedic surgery less invasive and more efficient, we remain committed to improving patient outcomes and surgical experiences. We believe this funding is not just a financial boost but a testament to our vision of transforming orthopedic care. We look forward to sharing our advancements as we progress and thank our investors for believing in our mission to redefine the standards of orthopedic surgery.